<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0011010'>Chronic</z:hpo> low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> and/or <z:hpo ids='HP_0001513'>obesity</z:hpo> are suggested to induce <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This cross-sectional study was performed to investigate the relationship between inflammatory biomarkers and CKD in non-<z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 106 non-<z:mp ids='MP_0001261'>obese</z:mp> Japanese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were recruited for the measurement of GFR, TNF, HMW adiponectin, leptin, hsCRP and some variables including urinary albumin </plain></SENT>
<SENT sid="3" pm="."><plain>BMI, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, and urinary albumin levels were 22.2±0.2kg/m(2) (17.1-24.9kg/m(2)), 0.76±0.02mg/dl (0.39-1.38mg/dl), 40.4±4.3mg/gCr (1.6-195.0mg/gCr), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>They were stratified into two groups based on the value of eGFR: low eGFR (eGFR&lt;60ml/min/1.73m(2)) and <z:mpath ids='MPATH_458'>normal</z:mpath> eGFR (eGFR&gt;60ml/min/1.73m(2)) </plain></SENT>
<SENT sid="5" pm="."><plain>Logistic regression analysis was used for statistical analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Whereas univariate logistic regression analysis showed that gender, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="3" ids="27226">uric acid</z:chebi>, urinary albumin, and soluble TNF receptors (sTNF-R1, sTNF-R2) are associated with the development of stage 3 CKD, multivariate logistic regression analysis revealed that sTNF-R2 (Odds ratio 1.003, 95% confidence interval 1.000 to 1.005, P=0.030) showed significant associations with the development of stage 3 CKD </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Circulating TNF receptor 2 is an independent risk factor for CKD in non-<z:mp ids='MP_0001261'>obese</z:mp> Japanese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>